Your session is about to expire
← Back to Search
Behavioral Intervention
Behavioral Intervention + Technology for Weight Loss
N/A
Recruiting
Led By Esra Tasali, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages 18 to 40 years
Weight stable (no change >25 lbs in the past 3 months)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to study how a combination of behavioral intervention and technology can help young adults lose weight. Obesity and related health risks are common issues, and current methods to address them are not always successful.
Who is the study for?
This trial is for overweight or obese young adults aged 18 to 40 with a BMI of 25.5-34.9, who have had stable weight in the last three months and own a smartphone they're willing to use for the study.
What is being tested?
The trial is testing two lifestyle interventions aimed at weight loss in young adults. It explores how behavioral changes combined with technology can help manage obesity and prevent related health risks.
What are the potential side effects?
Since this trial involves lifestyle interventions, side effects may include typical reactions to diet changes or increased physical activity such as muscle soreness, fatigue, or digestive adjustments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 40 years old.
Select...
My weight has been stable, with no change over 25 lbs in the last 3 months.
Select...
I own a smartphone and agree to install the study app.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Weight loss
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Lifestyle Intervention IIExperimental Treatment2 Interventions
Diet and exercise coaching
Group II: Lifestyle InterventionExperimental Treatment1 Intervention
Diet and exercise coaching
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lifestyle
2016
Completed Phase 4
~8600
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
1,062 Previous Clinical Trials
839,814 Total Patients Enrolled
15 Trials studying Obesity
1,985 Patients Enrolled for Obesity
Northwestern UniversityOTHER
1,652 Previous Clinical Trials
961,195 Total Patients Enrolled
34 Trials studying Obesity
11,462 Patients Enrolled for Obesity
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,464 Previous Clinical Trials
4,337,133 Total Patients Enrolled
473 Trials studying Obesity
591,014 Patients Enrolled for Obesity
Esra Tasali, MDPrincipal InvestigatorUniversity of Chicago
6 Previous Clinical Trials
751 Total Patients Enrolled
1 Trials studying Obesity
23 Patients Enrolled for Obesity